Dose‐Related Safety and Immunogenicity of a Trivalent Baculovirus‐Expressed Influenza‐Virus Hemagglutinin Vaccine in Elderly Adults | Zendy

John J. Treanor | Zendy; Gilbert M. Schiff | Zendy; Robert B. Couch | Zendy; Thomas R. Cate | Zendy; Rebecca C. Brady | Zendy; Christine M. Hay | Zendy; Mark Wolff | Zendy; Dewei She | Zendy; Ma Cox | Zendy

Open Access

Dose‐Related Safety and Immunogenicity of a Trivalent Baculovirus‐Expressed Influenza‐Virus Hemagglutinin Vaccine in Elderly Adults

Author(s) -

John J. Treanor,

Gilbert M. Schiff,

Robert B. Couch,

Thomas R. Cate,

Rebecca C. Brady,

Christine M. Hay,

Mark Wolff,

Dewei She,

Ma Cox

Publication year - 2006

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/503050

Subject(s) - immunogenicity , hemagglutinin (influenza) , virology , inactivated vaccine , influenza vaccine , virus , orthomyxoviridae , medicine , baculoviridae , trivalent influenza vaccine , vaccination , influenza a virus , recombinant dna , influenzavirus b , antibody , biology , immunology , gene , biochemistry , spodoptera

Influenza-virus hemagglutinin (HA) protein expressed in insect cells by recombinant baculovirus is a candidate influenza vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research